Medically reviewed by Christopher Lee, MDA heart attack and stroke are both serious health conditions that occur when there's ...

Using an innovative risk score assessment score, heart researchers at Intermountain Health in Salt Lake City say they can ...

GLP-1 agonist drugs like Ozempic, and SLGT2 inhibitor drugs like Jardiance have been linked with a lower risk of a second ...

A study by Cleveland Clinic and USC researchers long-term risk associated with COVID-19 “continues to pose a significant ...

Experts have started thinking more broadly about what puts a person at risk for heart disease, still the leading killer in the U.S.

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.

Sleep deprivation has become a common problem several people face on a daily basis. But, it may put you at risk of heart ...

In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor medication had a lower risk of a subsequent stroke, heart attack or death ...

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

A new study says that type 2 diabetes medications GLP-1 agonists and SGLT2 inhibitors may help lower a stroke survivor’s risk of experiencing a subsequent stroke, heart attack, or death ...